메뉴 건너뛰기




Volumn 8, Issue 1, 2004, Pages 48-53

Does primary chemotherapy really increase the rate of breast conserving treatments?;La chimiothérapie première permet-elle réellement d'augmenter le taux de conservation mammaire?

Author keywords

Breast cancer; Conservative treatment; Primary chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; MITOMYCIN C; MITOXANTRONE; PREDNISONE; TAMOXIFEN; THIOTEPA; VINCRISTINE; VINDESINE;

EID: 1242338231     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2003.10.009     Document Type: Short Survey
Times cited : (3)

References (45)
  • 1
    • 0038823558 scopus 로고    scopus 로고
    • Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate
    • Amat S., Bougnoux P., Penault-llorca F., Fétissof F., Curé H., Kwiatkowski F., et al. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer. 88:2003;1339-1345.
    • (2003) Br J Cancer , vol.88 , pp. 1339-1345
    • Amat, S.1    Bougnoux, P.2    Penault-Llorca, F.3    Fétissof, F.4    Curé, H.5    Kwiatkowski, F.6
  • 2
    • 85008998707 scopus 로고    scopus 로고
    • The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide: Preliminary results from NSABP protocol B-27
    • (abs.)
    • Bear H. The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide: preliminary results from NSABP protocol B-27. Breast Cancer Res Treat. 69:2001;201. (abs.).
    • (2001) Breast Cancer Res Treat , vol.69 , pp. 201
    • Bear, H.1
  • 4
    • 0037077831 scopus 로고    scopus 로고
    • Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy
    • Bertheau P., Plassa F., Espié M., Turpin E., de Rocquancourt A., Marty M., et al. Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet. 360:2002;852.
    • (2002) Lancet , vol.360 , pp. 852
    • Bertheau, P.1    Plassa, F.2    Espié, M.3    Turpin, E.4    De Rocquancourt, A.5    Marty, M.6
  • 5
    • 0031972858 scopus 로고    scopus 로고
    • Primary chemotherapy in operable breast cancer: Eight year experience at the Milan Cancer Institute
    • Bonadonna G., Valagussa P., Brambilla C., Ferrari L., Moliterni A., Terenziani M., et al. Primary chemotherapy in operable breast cancer: eight year experience at the Milan Cancer Institute. J Clin Oncol. 16:1998;1539-1545.
    • (1998) J Clin Oncol , vol.16 , pp. 1539-1545
    • Bonadonna, G.1    Valagussa, P.2    Brambilla, C.3    Ferrari, L.4    Moliterni, A.5    Terenziani, M.6
  • 6
    • 8244258025 scopus 로고    scopus 로고
    • Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    • Brain E., Garrino C., Misset J., Carbonero I., Itzhaki M., Cvitkovic E., et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer. 75:1997;1360-1367.
    • (1997) Br J Cancer , vol.75 , pp. 1360-1367
    • Brain, E.1    Garrino, C.2    Misset, J.3    Carbonero, I.4    Itzhaki, M.5    Cvitkovic, E.6
  • 7
    • 0033428140 scopus 로고    scopus 로고
    • Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial
    • Broet P., Scholl S., de la Rochefordière A., Fourquet A., Moreau T., De Rycke Y., et al. Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat. 58:1999;151-156.
    • (1999) Breast Cancer Res Treat , vol.58 , pp. 151-156
    • Broet, P.1    Scholl, S.2    De La Rochefordière, A.3    Fourquet, A.4    Moreau, T.5    De Rycke, Y.6
  • 8
    • 0028068245 scopus 로고
    • Conservative treatment feasibility with induction chemotherapy, Surgery, and Radiotherapy for patients with patients with breast carcinoma larger than 3 cm
    • Calais G., Berger C., Descamps P., Chapet S., Reynaud-Bougnoux A., Body G., et al. Conservative treatment feasibility with induction chemotherapy, Surgery, and Radiotherapy for patients with patients with breast carcinoma larger than 3 cm. Cancer. 74:1994;1283-1288.
    • (1994) Cancer , vol.74 , pp. 1283-1288
    • Calais, G.1    Berger, C.2    Descamps, P.3    Chapet, S.4    Reynaud-Bougnoux, A.5    Body, G.6
  • 9
    • 0032887665 scopus 로고    scopus 로고
    • Biological markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
    • Chang J., Powles T., Alred D., Ashley S., Clark G., Makris A., et al. Biological markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol. 17:1999;3058-3063.
    • (1999) J Clin Oncol , vol.17 , pp. 3058-3063
    • Chang, J.1    Powles, T.2    Alred, D.3    Ashley, S.4    Clark, G.5    Makris, A.6
  • 10
    • 0037687355 scopus 로고    scopus 로고
    • Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postopertaive adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/Cancer and Leukemia group B trial 9741
    • Citron M., Berry D., Cirrincione C., Hudis C., Winer E., Gradishar W., et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postopertaive adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and Leukemia group B trial 9741. J Clin Oncol. 21:2003;1431-1439.
    • (2003) J Clin Oncol , vol.21 , pp. 1431-1439
    • Citron, M.1    Berry, D.2    Cirrincione, C.3    Hudis, C.4    Winer, E.5    Gradishar, W.6
  • 13
    • 0008703742 scopus 로고
    • Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: A prospective randomized trial
    • Danforth D., Jacobson J., O'Shaugnessy J., Zujewski J., Riseberg D., Denicoff A., et al. Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: a prospective randomized trial. Proc Annu Meet Am Soc Clin Oncol. 14:1995;A213.
    • (1995) Proc Annu Meet Am Soc Clin Oncol , vol.14 , pp. 213
    • Danforth, D.1    Jacobson, J.2    O'Shaugnessy, J.3    Zujewski, J.4    Riseberg, D.5    Denicoff, A.6
  • 14
    • 0031982870 scopus 로고    scopus 로고
    • Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
    • Ellis P., Smith I., Ashley S., Walsh G., Ebbs S., Baum M., et al. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. J Clin Oncol. 16:1998;107-114.
    • (1998) J Clin Oncol , vol.16 , pp. 107-114
    • Ellis, P.1    Smith, I.2    Ashley, S.3    Walsh, G.4    Ebbs, S.5    Baum, M.6
  • 15
    • 0031926839 scopus 로고    scopus 로고
    • Effects of primary chemotherapy on the outcome of women with operable breast cancer
    • Fisher B., Bryant J., Wolmark N., Mamounas E., Brown A., Fisher E., et al. Effects of primary chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 16:1998;2672-2685.
    • (1998) J Clin Oncol , vol.16 , pp. 2672-2685
    • Fisher, B.1    Bryant, J.2    Wolmark, N.3    Mamounas, E.4    Brown, A.5    Fisher, E.6
  • 16
    • 0024553695 scopus 로고
    • Effect of local or systemic treatment prior to tumor removal on the production and response to a serum growth-stimulating factor in mice
    • Fisher B., Saffer E., Rudock C., Coyle J., Gunduz N. Effect of local or systemic treatment prior to tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res. 49:1989;2002-2004.
    • (1989) Cancer Res , vol.49 , pp. 2002-2004
    • Fisher, B.1    Saffer, E.2    Rudock, C.3    Coyle, J.4    Gunduz, N.5
  • 17
    • 0037103104 scopus 로고    scopus 로고
    • Pathobiology of preoperative chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel (NSABP) Protocol B-18
    • Fisher E., Wang J., Bryant J., Fisher B., Mamounas E., Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) Protocol B-18. Cancer. 95:2002;681-695.
    • (2002) Cancer , vol.95 , pp. 681-695
    • Fisher, E.1    Wang, J.2    Bryant, J.3    Fisher, B.4    Mamounas, E.5    Wolmark, N.6
  • 18
    • 0030657740 scopus 로고    scopus 로고
    • Original P53 status predicts for pathological response in locally advanced breast cancer patients preoperatively treated with continuous infusion 5-fluorouracil and radiation therapy
    • Formenti S., Dunnington G., Uzieli B., et al. Original P53 status predicts for pathological response in locally advanced breast cancer patients preoperatively treated with continuous infusion 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys. 39:1997;1059-1068.
    • (1997) Int J Radiat Oncol Biol Phys , vol.39 , pp. 1059-1068
    • Formenti, S.1    Dunnington, G.2    Uzieli, B.3
  • 19
    • 0036472185 scopus 로고    scopus 로고
    • Low HER2/Neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer
    • Formenti S., Spicer D., Skinner K., Cohen D., Groshen S., Bettini A., et al. Low HER2/Neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 52:2002;397-405.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 397-405
    • Formenti, S.1    Spicer, D.2    Skinner, K.3    Cohen, D.4    Groshen, S.5    Bettini, A.6
  • 20
    • 0037364373 scopus 로고    scopus 로고
    • Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial
    • Formenti S., Volm M., Skinner K., Spicer D., Cohen D., Perez E., et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. J Clin Oncol. 21:2003;864-870.
    • (2003) J Clin Oncol , vol.21 , pp. 864-870
    • Formenti, S.1    Volm, M.2    Skinner, K.3    Spicer, D.4    Cohen, D.5    Perez, E.6
  • 21
    • 0032944172 scopus 로고    scopus 로고
    • Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and post-operative radiotherapy
    • Fortin A., Larochelle M., Laverdière J., Lavertu S., Tremblay D. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and post-operative radiotherapy. J Clin Oncol. 17:1999;101-109.
    • (1999) J Clin Oncol , vol.17 , pp. 101-109
    • Fortin, A.1    Larochelle, M.2    Laverdière, J.3    Lavertu, S.4    Tremblay, D.5
  • 22
    • 0011715451 scopus 로고    scopus 로고
    • First report of the European Cooperative Trial in operable breast cancer (ECTO): Effect of primary systemic therapy (PST) on local-regional disease
    • Gianni L., Baselga J., Eiermann W., Guillem V., Semiglazov V., Garcia-Conde J., et al. First report of the European Cooperative Trial in operable breast cancer (ECTO): effect of primary systemic therapy (PST) on local-regional disease. Proc ASCO. 21:2002;132.
    • (2002) Proc ASCO , vol.21 , pp. 132
    • Gianni, L.1    Baselga, J.2    Eiermann, W.3    Guillem, V.4    Semiglazov, V.5    Garcia-Conde, J.6
  • 23
    • 0025288575 scopus 로고
    • Results of neo-adjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer
    • Jacquillat C., Weill M., Baillet F., Borel C., Auclerc G., de Maublanc M., et al. Results of neo-adjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 66:1990;119-129.
    • (1990) Cancer , vol.66 , pp. 119-129
    • Jacquillat, C.1    Weill, M.2    Baillet, F.3    Borel, C.4    Auclerc, G.5    De Maublanc, M.6
  • 24
    • 0038013982 scopus 로고    scopus 로고
    • International Expert Panel on the Use of Primary (preoperative) systemic treatment of operable breast Cancer: Review and recommandations
    • Kaufmann M., von Minckwitz G., Smith R., Valero V., Gianni L., Eiermann W., et al. International Expert Panel on the Use of Primary (preoperative) systemic treatment of operable breast Cancer: review and recommandations. J Clin Oncol. 21:2003;2600-2608.
    • (2003) J Clin Oncol , vol.21 , pp. 2600-2608
    • Kaufmann, M.1    Von Minckwitz, G.2    Smith, R.3    Valero, V.4    Gianni, L.5    Eiermann, W.6
  • 25
    • 0035705547 scopus 로고    scopus 로고
    • Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
    • Kuerer H., Singletary S., Buzdar A., Ames F., Valero V., Buchholz T., et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 182:2001;601-608.
    • (2001) Am J Surg , vol.182 , pp. 601-608
    • Kuerer, H.1    Singletary, S.2    Buzdar, A.3    Ames, F.4    Valero, V.5    Buchholz, T.6
  • 26
    • 0031743702 scopus 로고    scopus 로고
    • A reduction in the requirement for mastectomy in a randomized trial of neoadjuvant chemo-endocrine therapy in primary breast cancer
    • Makris A., Powles T., Ashley S., Chang J., Hickish T., Tidy V., et al. A reduction in the requirement for mastectomy in a randomized trial of neoadjuvant chemo-endocrine therapy in primary breast cancer. Ann Oncol. 9:1998;1179-1184.
    • (1998) Ann Oncol , vol.9 , pp. 1179-1184
    • Makris, A.1    Powles, T.2    Ashley, S.3    Chang, J.4    Hickish, T.5    Tidy, V.6
  • 28
    • 0033058219 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up - Institut Bergonié Bordeaux Groupe Sein (IBBGS)
    • Mauriac L., MacGrogan G., Avril A., Durand M., Floquet A., Debled M., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up - Institut Bergonié Bordeaux Groupe Sein (IBBGS). Ann Oncol. 10:1999;47-52.
    • (1999) Ann Oncol , vol.10 , pp. 47-52
    • Mauriac, L.1    MacGrogan, G.2    Avril, A.3    Durand, M.4    Floquet, A.5    Debled, M.6
  • 29
    • 0032885642 scopus 로고    scopus 로고
    • Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hossier Oncology Group
    • Miller K., Mc Caskill-Stevens W., Sisk J., Loesch D., Monaco F., Seshadri R., et al. Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: a randomized pilot trial of the Hossier Oncology Group. J Clin Oncol. 17:1999;3033-3037.
    • (1999) J Clin Oncol , vol.17 , pp. 3033-3037
    • Miller, K.1    Mc Caskill-Stevens, W.2    Sisk, J.3    Loesch, D.4    Monaco, F.5    Seshadri, R.6
  • 30
    • 0023860354 scopus 로고
    • Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A cancer and leukemia group B study
    • Perloff M., Lesnick G., Korzun A., Chu F., Holland J., Thirlwell M., et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a cancer and leukemia group B study. J Clin Oncol. 6:1988;261-269.
    • (1988) J Clin Oncol , vol.6 , pp. 261-269
    • Perloff, M.1    Lesnick, G.2    Korzun, A.3    Chu, F.4    Holland, J.5    Thirlwell, M.6
  • 31
    • 0038740871 scopus 로고    scopus 로고
    • Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. The role of clinical response
    • Pierga J., Mouret E., Laurence V., Savigioni A., Beuzeboc P., Dorval T., et al. Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. The role of clinical response. Eur J Cancer. 39:2003;1089-1096.
    • (2003) Eur J Cancer , vol.39 , pp. 1089-1096
    • Pierga, J.1    Mouret, E.2    Laurence, V.3    Savigioni, A.4    Beuzeboc, P.5    Dorval, T.6
  • 32
    • 0013108215 scopus 로고    scopus 로고
    • Preoperative versus postoperative adjuvant chemotherapy for stage I-II breast cancer. Long-term analysis of British Columbia randomized trial
    • Ragaz J., Baird R., Rebbeck P., Trevisan C., Goldie J., Coldman A. Preoperative versus postoperative adjuvant chemotherapy for stage I-II breast cancer. Long-term analysis of British Columbia randomized trial. Proc Annu Meet Am Soc Clin Oncol. 16:1997;A499.
    • (1997) Proc Annu Meet Am Soc Clin Oncol , vol.16 , pp. 499
    • Ragaz, J.1    Baird, R.2    Rebbeck, P.3    Trevisan, C.4    Goldie, J.5    Coldman, A.6
  • 33
    • 0036498789 scopus 로고    scopus 로고
    • Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes
    • Rouzier R., Extra J., Klijanienko J., Falcou M., Asselain B., Vincent-Salomon A., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 20:2002;1304-1310.
    • (2002) J Clin Oncol , vol.20 , pp. 1304-1310
    • Rouzier, R.1    Extra, J.2    Klijanienko, J.3    Falcou, M.4    Asselain, B.5    Vincent-Salomon, A.6
  • 34
    • 0027522333 scopus 로고
    • Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer
    • Sauter E., Eisenberg B., Hoffman J., Ottery F., Boraas M., Goldstein L., et al. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg. 17:1993;237-242.
    • (1993) World J Surg , vol.17 , pp. 237-242
    • Sauter, E.1    Eisenberg, B.2    Hoffman, J.3    Ottery, F.4    Boraas, M.5    Goldstein, L.6
  • 35
    • 0028357653 scopus 로고
    • Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours ceonsidered too large for breast conserving surgery: Premiminary results of a randomised trial S6
    • Scholl S., Fourquet A., Asselain B., Pierga J., Vilcoq J., Durand J., et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours ceonsidered too large for breast conserving surgery: premiminary results of a randomised trial S6. Eur J Cancer. 30A:1994;645-652.
    • (1994) Eur J Cancer , vol.30 , pp. 645-652
    • Scholl, S.1    Fourquet, A.2    Asselain, B.3    Pierga, J.4    Vilcoq, J.5    Durand, J.6
  • 36
    • 0028048459 scopus 로고
    • Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIB-IIIA breast cancer
    • Semiglazov V., Topuzov E., Bavli J., Moiseyenko V., Ivanova O., Seleznev I., et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIB-IIIA breast cancer. Ann Oncol. 5:1994;591-595.
    • (1994) Ann Oncol , vol.5 , pp. 591-595
    • Semiglazov, V.1    Topuzov, E.2    Bavli, J.3    Moiseyenko, V.4    Ivanova, O.5    Seleznev, I.6
  • 37
    • 0037087562 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
    • Smith I., Heys S., Hutcheon A., Miler I., Payne S., Gilbert F., et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 20:2002;1456-1466.
    • (2002) J Clin Oncol , vol.20 , pp. 1456-1466
    • Smith, I.1    Heys, S.2    Hutcheon, A.3    Miler, I.4    Payne, S.5    Gilbert, F.6
  • 38
    • 0027506734 scopus 로고
    • Primary medical (neo-adjuvant)chemotherapy for operable breast cancer
    • Smith I., Jones A., O'Brien M., McKinna J., Sacks N., Baum M. Primary medical (neo-adjuvant)chemotherapy for operable breast cancer. Eur J Cancer. 29A:1993;592-595.
    • (1993) Eur J Cancer , vol.29 , pp. 592-595
    • Smith, I.1    Jones, A.2    O'Brien, M.3    McKinna, J.4    Sacks, N.5    Baum, M.6
  • 39
    • 0035468731 scopus 로고    scopus 로고
    • Preoperative/neoadjuvant medical therapy for early breast cancer
    • Smith I., Lipton L. Preoperative/neoadjuvant medical therapy for early breast cancer. Lancet Oncol. 2:2001;561-570.
    • (2001) Lancet Oncol , vol.2 , pp. 561-570
    • Smith, I.1    Lipton, L.2
  • 40
    • 0030936891 scopus 로고    scopus 로고
    • Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer
    • Touboul E., Lefranc J., Blondon J., Buffat L., Deniaud E., Belkacémi Y., et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radioth. Oncol. 42:1997;219-229.
    • (1997) Radioth. Oncol. , vol.42 , pp. 219-229
    • Touboul, E.1    Lefranc, J.2    Blondon, J.3    Buffat, L.4    Deniaud, E.5    Belkacémi, Y.6
  • 41
    • 0035890633 scopus 로고    scopus 로고
    • Preoperative chemotherapy in primary operable breast cancer: Results from the European organization for research and treatment of cancer trial 10902
    • van der Hage J., van de Velde C., Julien J., Tubian-Hulin M., Vandervelden C., Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902. J Clin Oncol. 19:2001;4224-4237.
    • (2001) J Clin Oncol , vol.19 , pp. 4224-4237
    • Van Der Hage, J.1    Van De Velde, C.2    Julien, J.3    Tubian-Hulin, M.4    Vandervelden, C.5    Duchateau, L.6
  • 42
    • 0034653910 scopus 로고    scopus 로고
    • The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after downstaging with induction chemotherapy
    • Vlastos G., Mirza N., Lenert J., Hunt K., Ames F., Feig B., et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after downstaging with induction chemotherapy. Cancer. 88:2000;1417-1424.
    • (2000) Cancer , vol.88 , pp. 1417-1424
    • Vlastos, G.1    Mirza, N.2    Lenert, J.3    Hunt, K.4    Ames, F.5    Feig, B.6
  • 43
    • 0033060223 scopus 로고    scopus 로고
    • Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel
    • von Minckwitz G., Dan Costa S., Eiermann W., Blohmer J., Tulusan A., Jackisch C., et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol. 17:1999;1999-2005.
    • (1999) J Clin Oncol , vol.17 , pp. 1999-2005
    • Von Minckwitz, G.1    Dan Costa, S.2    Eiermann, W.3    Blohmer, J.4    Tulusan, A.5    Jackisch, C.6
  • 44
    • 0034035650 scopus 로고    scopus 로고
    • Primary systemic therapy in operable breast cancer
    • Wolff A., Davidson N. Primary systemic therapy in operable breast cancer. J Clin Oncol. 18:2000;1558-1569.
    • (2000) J Clin Oncol , vol.18 , pp. 1558-1569
    • Wolff, A.1    Davidson, N.2
  • 45
    • 0035751675 scopus 로고    scopus 로고
    • Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from national surgical adjuvant breast and bowel project B-18
    • Wolmark N., Wang J., Mamounas E., Bryant J., Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from national surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monogr. 30:2001;96-102.
    • (2001) J Natl Cancer Inst Monogr , vol.30 , pp. 96-102
    • Wolmark, N.1    Wang, J.2    Mamounas, E.3    Bryant, J.4    Fisher, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.